Total Payments
$4,086
2024 Payments
$215.39
Companies
18
Transactions
77
Medicare Patients
3,193
Medicare Billing
$616,482
Payment Breakdown by Category
Food & Beverage$2,330 (57.0%)
Other$1,500 (36.7%)
Education$208.69 (5.1%)
Travel$47.45 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,330 | 54 | 57.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 1 | 36.7% |
| Education | $208.69 | 20 | 5.1% |
| Travel and Lodging | $47.45 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $2,040 | 11 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $536.95 | 12 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $255.35 | 11 | $0 (2024) |
| Mallinckrodt LLC | $203.81 | 11 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $160.26 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $153.17 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $140.31 | 6 | $0 (2024) |
| Horizon Pharma plc | $121.09 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $112.02 | 1 | $0 (2017) |
| Vifor Pharma, Inc. | $104.17 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $215.39 | 15 | Novartis Pharmaceuticals Corporation ($121.12) |
| 2023 | $164.42 | 3 | Mallinckrodt Hospital Products Inc. ($121.84) |
| 2022 | $167.55 | 4 | Vifor Pharma, Inc. ($104.17) |
| 2021 | $153.39 | 4 | AstraZeneca Pharmaceuticals LP ($114.45) |
| 2020 | $65.66 | 4 | Mallinckrodt Hospital Products Inc. ($38.42) |
| 2019 | $575.23 | 17 | Fresenius USA Marketing, Inc. ($190.97) |
| 2018 | $683.18 | 12 | Otsuka America Pharmaceutical, Inc. ($244.77) |
| 2017 | $2,061 | 18 | Relypsa, Inc. ($1,665) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $42.82 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 07/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.12 | General |
| 05/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 04/23/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 04/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.47 | General |
| 04/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardio-renal | ||||||
| 03/20/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $17.75 | General |
| 01/17/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.71 | General |
| 01/17/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 01/17/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 01/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.13 | General |
| 11/15/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: NEPHROLOGY | ||||||
| 05/18/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: CRITICAL CARE | ||||||
| 04/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/19/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: NEPHROLOGY | ||||||
| 06/09/2022 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $104.17 | General |
| 03/24/2022 | Amgen Inc. | Tavneos (Drug) | Education | In-kind items and services | $20.08 | General |
| Category: Not Applicable | ||||||
| 09/09/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2021 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: ONCOLOGY | ||||||
| 05/12/2021 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 892 | 1,817 | $405,879 | $166,051 |
| 2022 | 13 | 740 | 1,322 | $299,580 | $124,311 |
| 2021 | 14 | 777 | 1,477 | $376,614 | $161,588 |
| 2020 | 15 | 784 | 1,596 | $423,422 | $164,531 |
Total Patients
3,193
Total Services
6,212
Medicare Billing
$616,482
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 255 | 678 | $96,954 | $41,621 | 42.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 164 | 170 | $68,170 | $22,497 | 33.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 90 | 219 | $45,114 | $20,186 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 239 | $50,429 | $18,544 | 36.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 18 | 65 | $36,660 | $18,015 | 49.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 13 | 55 | $26,015 | $11,757 | 45.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 21 | 45 | $21,285 | $10,322 | 48.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 62 | 168 | $24,528 | $9,307 | 37.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 64 | $17,472 | $6,458 | 37.0% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 18 | 64 | $10,880 | $4,224 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,852 | $1,319 | 34.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 22 | $2,200 | $970.48 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 16 | $2,320 | $831.84 | 35.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 212 | 513 | $73,359 | $28,273 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 118 | 122 | $48,922 | $18,794 | 38.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 18 | 53 | $29,892 | $14,866 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 149 | $31,439 | $13,384 | 42.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 81 | 156 | $32,136 | $12,225 | 38.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 11 | 50 | $23,650 | $11,061 | 46.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 16 | 32 | $15,136 | $7,507 | 49.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 48 | $13,104 | $4,995 | 38.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 51 | 85 | $12,410 | $4,855 | 39.1% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 18 | 46 | $7,820 | $3,127 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 43 | $6,235 | $2,676 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,852 | $1,452 | 37.7% |
About Dr. Natthavat Tanphaichitr, M.D
Dr. Natthavat Tanphaichitr, M.D is a Nephrology healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669587523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Natthavat Tanphaichitr, M.D has received a total of $4,086 in payments from pharmaceutical and medical device companies, with $215.39 received in 2024. These payments were reported across 77 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,330).
As a Medicare-enrolled provider, Tanphaichitr has provided services to 3,193 Medicare beneficiaries, totaling 6,212 services with total Medicare billing of $616,482. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Akron, OH
- Active Since 08/20/2006
- Last Updated 01/26/2017
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1669587523
Products in Payments
- Veltassa (Drug) $2,040
- JYNARQUE (Drug) $414.36
- ACTHAR (Biological) $242.23
- Velphoro (Drug) $191.01
- SAMSCA (Drug) $122.59
- TERLIVAZ (Drug) $121.84
- KRYSTEXXA (Drug) $121.09
- SOLIRIS (Drug) $112.02
- BRILINTA (Drug) $99.99
- NephroCheck Test (Device) $66.42
- Fabhalta (Drug) $42.82
- Parsabiv (Biological) $42.73
- SYSTEM ONE (Device) $29.90
- FARXIGA (Drug) $29.73
- LOKELMA (Drug) $23.45
- Tavneos (Drug) $20.08
- LUPKYNIS (Drug) $19.42
- Kerendia (Drug) $19.33
- AFINITOR (Drug) $19.19
- Dialyzers (Device) $12.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Akron
Adrian Ochoa, Md, MD
Nephrology — Payments: $1,739
Nephrology $1,739
Olga Voroshilova, M.d, M.D
Nephrology — Payments: $1,371
Nephrology $1,371
Miriam Zidehsarai, D.o, D.O
Nephrology — Payments: $1,143
Nephrology $1,143
Thomas Kayani, Md, MD
Nephrology — Payments: $1,112
Nephrology $1,112
Dr. Jayaprakash Dasari, M.d, M.D
Nephrology — Payments: $1,047
Nephrology $1,047
Aziz Bakhous, M.d, M.D
Nephrology — Payments: $1,041
Nephrology $1,041